These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11791795)

  • 1. Inherited factor H dysfunction and complement-associated glomerulonephritis in renal grafts of first and second transplantations.
    Watanabe S; Yamaguchi Y; Suzuki T; Ikezoe M; Matsumoto N; Chikamoto H; Nagafuchi H; Horita S; Hattori M; Shiraga H; Tokumoto T; Tanabe K; Toma H; Ito K
    Clin Transplant; 2001; 15 Suppl 5():45-50. PubMed ID: 11791795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ complement activation in porcine membranoproliferative glomerulonephritis type II.
    Jansen JH; Høgåsen K; Harboe M; Hovig T
    Kidney Int; 1998 Feb; 53(2):331-49. PubMed ID: 9461093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
    Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
    Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
    West CD; McAdams AJ
    Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous histologic and clinical evolution in 3 cases of dense deposit disease with long-term follow-up.
    Figuères ML; Frémeaux-Bacchi V; Rabant M; Galmiche L; Marinozzi MC; Grünfeld JP; Noël LH; Servais A
    Hum Pathol; 2014 Nov; 45(11):2326-33. PubMed ID: 25260719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.
    Sethi S; Fervenza FC; Zhang Y; Nasr SH; Leung N; Vrana J; Cramer C; Nester CM; Smith RJ
    Clin J Am Soc Nephrol; 2011 May; 6(5):1009-17. PubMed ID: 21415311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
    Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo C3 glomerulonephritis in a renal allograft.
    Nahm JH; Song SH; Kim YS; Cheong HI; Lim BJ; Kim BS; Jeong HJ
    Ultrastruct Pathol; 2016; 40(2):112-5. PubMed ID: 26986539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
    West CD; McAdams AJ
    Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prominent subepithelial deposits detected on 2nd renal biopsy in a boy with membranoproliferative glomerulonephritis type I: a case report].
    Motoyama O; Ohshima M; Kawamura S; Iitaka K
    Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):247-52. PubMed ID: 7602812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental models of membranoproliferative glomerulonephritis, including dense deposit disease.
    Vernon KA; Pickering MC; Cook T
    Contrib Nephrol; 2011; 169():198-210. PubMed ID: 21252520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
    Sethi S; Fervenza FC; Zhang Y; Zand L; Vrana JA; Nasr SH; Theis JD; Dogan A; Smith RJ
    Kidney Int; 2012 Aug; 82(4):465-73. PubMed ID: 22673887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of rapid progressive glomerulonephritis with IgA deposits after renal transplantation.
    Shimizu T; Tanabe K; Tokumoto T; Shimmura H; Koga S; Ishikawa N; Oshima T; Toma H; Yamaguchi Y
    Clin Transplant; 2001; 15 Suppl 5():11-5. PubMed ID: 11791788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
    Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
    Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Deposits with a Striated Ultrastructure.
    Namba-Hamano T; Hamano T; Imamura R; Yamaguchi Y; Kyo M; Yonishi H; Takahashi A; Kawamura M; Nakazawa S; Kato T; Abe T; Kyakuno M; Takabatake Y; Nonomura N; Isaka Y
    Nephron; 2020; 144 Suppl 1():43-48. PubMed ID: 33227797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranoproliferative glomerulonephritis with isolated C3 deposits: case report and literature review.
    Darouich S; Goucha R; Jaafoura MH; Zekri S; Kheder A; Ben Maiz H
    Ultrastruct Pathol; 2011 Feb; 35(1):42-6. PubMed ID: 21265634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology after eculizumab in dense deposit disease and C3 GN.
    Herlitz LC; Bomback AS; Markowitz GS; Stokes MB; Smith RN; Colvin RB; Appel GB; D'Agati VD
    J Am Soc Nephrol; 2012 Jul; 23(7):1229-37. PubMed ID: 22677550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.